Emerging Treatments for Retinopathy of Prematurity

Screening and treatments using telemedicine in retinopathy of prematurity

Several studies have validated the role of telemedicine as a new powerful screening and diagnostic tool for retinal disorders, such as diabetic retinopathy and retinopathy of prematurity. With regard to retinopathy of prematurity, bedside examination with binocular indirect ophthalmoscopy has been the gold standard technique for screening, yet with several limitations. Herein, we review the cur...

Retinopathy of Prematurity: An emerging and evolving challenge

The World Health Organization has identified retinopathy of prematurity (ROP) as an emerging cause of childhood blindness in developing and middle‐income countries. It is becoming a major public health problem in developing countries such as India and China. ROP blindness in India is increasing due to the highest number of preterm births in the world (3,519,100),[1] suboptimal neonatal care, la...

Retinopathy of prematurity in Brazil: an emerging problem.

The tragedy of blindness from retinopathy of prematurity (ROP) does not arise from a lack of knowledge about the disease. Based on results of large multicenter trials, we know when sight-threatening acute retinopathy is most likely to develop, we know that babies at risk are usually in hospital undermedical care, andwehave treatments currently available that have been proven effective in marked...

Bevacizumab for retinopathy of prematurity.

Screening for retinopathy of prematurity.

The demise of retinopathy of prematurity (ROP) was confidently forecast in the 1950s when supplemental oxygen was identified as a causal factor. Unfortunately this did not transpire and by the mid-1960s it became all too apparent that ROP was not solely of historical interest. The purpose of this article is to consider screening for ROP working on the basis that at present this condition is not...